Tighter Controls, Flood Of Orders Force Chinese Medical Suppliers To Say 'No' To The World
As global buyers rush to order protective face masks, testing kits and ventilators from China, the world's largest medical supplies producer, some manufacturers are refusing to take the orders.
You may also be interested in...
A lack of Emergency Use Authorization potentially jeopardizes China’s efforts to fight the deadly virus outbreak, says a regulatory veteran.
The general economic and business impact on European firms from the coronavirus in China is widespread and severe, and companies must consider diversifying, warns an influential European trade group in a just-released business survey. But it concedes there are no China alternatives.
Increasingly looking to China to commercialize their latest therapies, multinationals may be leaping into unknown waters to navigate an intellectual property judiciary and administrative maze, in a country where some copy drugs have been approved before patent expiry. With a government trying to balance innovation and access, two recent rulings involving AstraZeneca shed rare light onto China’s protections for innovation, with advisors pointing to challenges and success factors.